Convergence Investment Partners’s Trueblue TBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
– Sell
-821
Closed -$21K – 832
2018
Q1
$21K Sell
821
-49,681
-98% -$1.36M ﹤0.01% 587
2017
Q4
$1.39M Sell
50,502
-14,770
-23% -$392K 0.19% 200
2017
Q3
$1.47M Buy
+65,272
New +$1.48M 0.21% 188
2016
Q3
– Sell
-81,130
Closed -$1.53M – 386
2016
Q2
$1.53M Buy
+81,130
New +$1.69M 0.21% 181
2015
Q4
– Sell
-50,712
Closed -$1.14M – 382
2015
Q3
$1.14M Buy
50,712
+20,584
+68% +$528K 0.13% 240
2015
Q2
$901K Buy
+30,128
New +$849K 0.09% 282
2014
Q3
– Sell
-39,800
Closed -$1.1M – 426
2014
Q2
$1.1M Buy
+39,800
New +$1.09M 0.14% 216

Other funds holding TBI

Convergence Investment Partners's TBI Position: Q2 2018 in Review

Convergence Investment Partners sold out of Trueblue (TBI) in Q2 2018, closing a stake of 821 shares — an estimated $21K sold.

Convergence Investment Partners first reported a position in TBI in Q2 2014 and held it in 7 quarters. The position peaked at $1.53M in Q2 2016. 194 funds tracked by Wall St. Rank hold TBI as of Q2 2018.

  • Convergence Investment Partners reported no remaining Trueblue position as of Q2 2018 after selling out during the quarter.
  • Convergence Investment Partners sold 821 Trueblue shares in Q2 2018, an estimated $21K.
  • Convergence Investment Partners first reported a position in Trueblue in Q2 2014 and held it in 7 quarters.
  • Convergence Investment Partners's Trueblue position peaked at $1.53M in Q2 2016.
  • 194 funds tracked by Wall St. Rank held Trueblue as of Q2 2018.

Based on Convergence Investment Partners's 13F filing for Q2 2018, filed 7 Aug 2018.